LBA
ONCR

Letko, Brosseau & Associates’s Oncorus, Inc. ONCR Stock Holding History

Letko, Brosseau & Associates’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-59,150
Closed -$50K – 103
2022
Q3 		$50K Hold
59,150
– – ﹤0.01% 100
2022
Q2 		$75K Hold
59,150
– – ﹤0.01% 98
2022
Q1 		$105K Buy
59,150
+34,400
+139% +$96.4K ﹤0.01% 100
2021
Q4 		$130K Hold
24,750
– – ﹤0.01% 106
2021
Q3 		$231K Hold
24,750
– – ﹤0.01% 103
2021
Q2 		$342K Buy
24,750
+5,000
+25% +$77.2K ﹤0.01% 97
2021
Q1 		$275K Buy
19,750
+8,750
+80% +$181K ﹤0.01% 100
2020
Q4 		$356K Buy
+11,000
New +$255K ﹤0.01% 100

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Letko, Brosseau & Associates's ONCR Position: Q4 2022 in Review

Letko, Brosseau & Associates sold out of Oncorus, Inc. (ONCR) in Q4 2022, closing a stake of 59,150 shares — an estimated $50K sold.

Letko, Brosseau & Associates first reported a position in ONCR in Q4 2020 and held it in 8 quarters. The position peaked at $356K in Q4 2020. 33 funds tracked by Wall St. Rank hold ONCR as of Q4 2022.

  • Letko, Brosseau & Associates reported no remaining Oncorus, Inc. position as of Q4 2022 after selling out during the quarter.
  • Letko, Brosseau & Associates sold 59,150 Oncorus, Inc. shares in Q4 2022, an estimated $50K.
  • Letko, Brosseau & Associates first reported a position in Oncorus, Inc. in Q4 2020 and held it in 8 quarters.
  • Letko, Brosseau & Associates's Oncorus, Inc. position peaked at $356K in Q4 2020.
  • 33 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q4 2022.

Based on Letko, Brosseau & Associates's 13F filing for Q4 2022, filed 10 Feb 2023.